Bioequivalence Study of 500 mg and 1000 mg Glucophage (Metformin) Tablets Manufactured by Bristol-Myers Squibb Relative to 500 mg and 1000 mg Diabex (Metformin) Tablets Marketed in Australia by Alphapharm Administered to Healthy Subjects in the Fed State

Name: Bioequivalence Study of 500 mg and 1000 mg Glucophage (Metformin) Tablets Manufactured by Bristol-Myers Squibb Relative to 500 mg and 1000 mg Diabex (Metformin) Tablets Marketed in Australia by Alphapharm Administered to Healthy Subjects in the Fed State
Creator: Vivli
Published: 2025-03-04 16:14:35
License: 暂无描述

DataCite Commons2025-03-04 更新2026-05-07 收录

下载链接：

https://search.vivli.org/doiLanding/studies/PR00008145/isLanding

下载链接

链接失效反馈

官方服务：

资源简介：

To demonstrate the bioequivalence of 500 mg and 1000 mg Glucophage tablets manufactured by BMS relative to the respective strengths of 500 mg and 1000 mg Diabex tablets marketed in Australia by Alphapharm in the fed state

提供机构：

Vivli

创建时间：

2022-06-29